Neuroimaging stroke diagnostic startup takes top award from among five finalists
LOS ANGELES – June 27, 2023 – MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced that StrokeDx, a medical device company developing low-cost, point-of-care neuroimaging for rapid diagnosis and monitoring of stroke, was named the 2023 Vision Award Winner at Wilson Sonsini Goodrich & Rosati’s 30th Annual Medical Device Digital Health Conference. StrokeDx was among five finalists from the 2023 Accelerator cohort who were selected to compete for the award at WSGR, where the company received the most votes.
StrokeDx’s mission is to transform stroke diagnostic paradigms by delivering faster and more accurate results to healthcare providers, ultimately saving crucial time in critical situations. The company’s innovative technology combines state-of-the-art engineering, novel algorithms, and exceptional end-user design. As the 2023 Vision Award winner, StrokeDx received a $10,500 non-dilutive cash prize and will be profiled in MedTech Strategist.
“We are honored to win this year’s Vision Award among the remarkable companies in the 2023 cohort. Our mission is to revolutionize stroke care with our novel, low-cost, portable technology. By accelerating stroke care in the pre-early-hospital setting and providing objective inpatient monitoring, we aim to save countless lives globally,” said Alexander Ballatori, CEO of StrokeDx. “We thank MedTech Innovator for this platform and look forward to the rest of the exciting program. Together, the 2023 cohort is reshaping the future of healthcare.”